Donor-Derived Malignancy and Transplantation Morbidity: Risks of Patient and Donor Genetics in Allogeneic Hematopoietic Stem Cell Transplantation.
Transplantation and Cellular Therapy(2023)
Key words
Allogeneic hematopoi- etic stem cell transplantation,Donor-derived malignancy,Hereditary hematologic syndromes,Clonal hematopoiesis,Donor selection
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined